Table 3.
Reasons for Discontinuing Active Surveillance | n | Percentage of Cohort (391 Patients) |
---|---|---|
Still on active surveillance | 183 | 46.8% |
Disease progression | 95 | 24.3% |
Convert to watchful waiting | 26 | 6.6% |
Patients choice for active treatment | 3 | 0.8% |
Lost to follow-up | 68 | 17.4% |
Death | 16 | 4.1% |
Total | 391 | 100% |